Pregabalin Sandoz GmbH

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
12-10-2023
Ciri produk Ciri produk (SPC)
12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
12-10-2023

Bahan aktif:

pregabalin

Boleh didapati daripada:

Sandoz GmbH

Kod ATC:

N03AX16

INN (Nama Antarabangsa):

pregabalin

Kumpulan terapeutik:

Antiepileptics,

Kawasan terapeutik:

Anxiety Disorders; Epilepsy

Tanda-tanda terapeutik:

EpilepsyPregabalin Sandoz GmbH is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Sandoz GmbH is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Ringkasan produk:

Revision: 16

Status kebenaran:

Withdrawn

Tarikh kebenaran:

2015-06-19

Risalah maklumat

                                70
B. PACKAGE LEAFLET
Medicinal product no longer authorised
71
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN SANDOZ GMBH 25 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 50 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 75 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 100 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 150 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 200 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 225 MG HARD CAPSULES
PREGABALIN SANDOZ GMBH 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Pregabalin Sandoz GmbH is and what it is used for
2. What you need to know before you take Pregabalin Sandoz GmbH
3. How to take Pregabalin Sandoz GmbH
4. Possible side effects
5. How to store Pregabalin Sandoz GmbH
6. Contents of the pack and other information
1.
WHAT PREGABALIN SANDOZ GMBH IS AND WHAT IT IS USED FOR
Pregabalin Sandoz GmbH belongs to a group of medicines used to treat
epilepsy and Generalised
Anxiety Disorder (GAD) in adults.
EPILEPSY:
Pregabalin Sandoz GmbH is used to treat a certain form of epilepsy
(partial seizures with or
without secondary generalisation) in adults. Your doctor will
prescribe Pregabalin Sandoz GmbH for
you to help treat your epilepsy when your current treatment is not
controlling your condition. You
should take Pregabalin Sandoz GmbH in addition to your current
treatment. Pregabalin Sandoz GmbH
is not intended to be used alone, but should always be used in
combination with other anti-epileptic
treatment.
GENERALISED ANXIETY DISORDER:
Pregabalin Sandoz
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
Medicinal product no longer authorised
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Sandoz GmbH 25 mg hard capsules
Pregabalin Sandoz GmbH 50 mg hard capsules
Pregabalin Sandoz GmbH 75 mg hard capsules
Pregabalin Sandoz GmbH 100 mg hard capsules
Pregabalin Sandoz GmbH 150 mg hard capsules
Pregabalin Sandoz GmbH 200 mg hard capsules
Pregabalin Sandoz GmbH 225 mg hard capsules
Pregabalin Sandoz GmbH 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Sandoz GmbH 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Sandoz GmbH 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Sandoz GmbH 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Pregabalin Sandoz GmbH 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Sandoz GmbH 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Pregabalin Sandoz GmbH 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Pregabalin Sandoz GmbH 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Sandoz GmbH 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsule.
Pregabalin Sandoz GmbH 25 mg hard capsules
Pale yellow-brown opaque cap and body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
Pregabalin Sandoz GmbH 50 mg hard capsules
Light yellow opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm),
filled with white to nearly
white coloured powder.
Pregabalin Sandoz GmbH 75 mg hard capsules
Red opaque cap and white opaque body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
Medicinal product no longer authorised
3
Pregabalin Sandoz GmbH 100 mg hard capsules
Red opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm), filled
with white to nearly white
coloured powder.
Pregabalin Sandoz
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 12-10-2023
Ciri produk Ciri produk Bulgaria 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 12-10-2023
Risalah maklumat Risalah maklumat Sepanyol 12-10-2023
Ciri produk Ciri produk Sepanyol 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 12-10-2023
Risalah maklumat Risalah maklumat Czech 12-10-2023
Ciri produk Ciri produk Czech 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Czech 12-10-2023
Risalah maklumat Risalah maklumat Denmark 12-10-2023
Ciri produk Ciri produk Denmark 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 12-10-2023
Risalah maklumat Risalah maklumat Jerman 12-10-2023
Ciri produk Ciri produk Jerman 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 12-10-2023
Risalah maklumat Risalah maklumat Estonia 12-10-2023
Ciri produk Ciri produk Estonia 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 12-10-2023
Risalah maklumat Risalah maklumat Greek 12-10-2023
Ciri produk Ciri produk Greek 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Greek 12-10-2023
Risalah maklumat Risalah maklumat Perancis 12-10-2023
Ciri produk Ciri produk Perancis 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 12-10-2023
Risalah maklumat Risalah maklumat Itali 12-10-2023
Ciri produk Ciri produk Itali 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Itali 12-10-2023
Risalah maklumat Risalah maklumat Latvia 12-10-2023
Ciri produk Ciri produk Latvia 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 12-10-2023
Risalah maklumat Risalah maklumat Lithuania 12-10-2023
Ciri produk Ciri produk Lithuania 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 12-10-2023
Risalah maklumat Risalah maklumat Hungary 12-10-2023
Ciri produk Ciri produk Hungary 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 12-10-2023
Risalah maklumat Risalah maklumat Malta 12-10-2023
Ciri produk Ciri produk Malta 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Malta 12-10-2023
Risalah maklumat Risalah maklumat Belanda 12-10-2023
Ciri produk Ciri produk Belanda 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 12-10-2023
Risalah maklumat Risalah maklumat Poland 12-10-2023
Ciri produk Ciri produk Poland 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Poland 12-10-2023
Risalah maklumat Risalah maklumat Portugis 12-10-2023
Ciri produk Ciri produk Portugis 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 12-10-2023
Risalah maklumat Risalah maklumat Romania 12-10-2023
Ciri produk Ciri produk Romania 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Romania 12-10-2023
Risalah maklumat Risalah maklumat Slovak 12-10-2023
Ciri produk Ciri produk Slovak 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 12-10-2023
Risalah maklumat Risalah maklumat Slovenia 12-10-2023
Ciri produk Ciri produk Slovenia 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 12-10-2023
Risalah maklumat Risalah maklumat Finland 12-10-2023
Ciri produk Ciri produk Finland 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Finland 12-10-2023
Risalah maklumat Risalah maklumat Sweden 12-10-2023
Ciri produk Ciri produk Sweden 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 12-10-2023
Risalah maklumat Risalah maklumat Norway 12-10-2023
Ciri produk Ciri produk Norway 12-10-2023
Risalah maklumat Risalah maklumat Iceland 12-10-2023
Ciri produk Ciri produk Iceland 12-10-2023
Risalah maklumat Risalah maklumat Croat 12-10-2023
Ciri produk Ciri produk Croat 12-10-2023
Laporan Penilaian Awam Laporan Penilaian Awam Croat 12-10-2023

Cari amaran yang berkaitan dengan produk ini